Mouhamed Yazan Abou-Ismail MD
Clotting Disorder, Hemophilia & Bleeding Disorder
Assistant Professor of Medicine
Join to View Full Profile
2000 Circle of HopeSalt Lake City, UT 84112
Phone+1 801-213-1203
Dr. Abou-Ismail is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Mouhamed Yazan Abou-Ismail, MD, is a hematologist based in Salt Lake City, UT, specializing in bleeding disorders, thrombosis, and classical hematological disorders. He completed his residency in Internal Medicine at Rochester General Hospital and a fellowship in Hematology and Medical Oncology at Case Western Reserve University. Currently, he serves as an Assistant Professor at the University of Utah Health. His research and clinical expertise include conditions like thrombotic thrombocytopenic purpura, thrombocytopenia, and von Willebrand disease, with many peer-reviewed publications in reputable journals. Additionally, he is a clinical investigator with research experience in various hematologic conditions. He currently serves as the associate program director of the hematology and oncology fellowship program.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 2017 - 2020
Rochester General HospitalResidency, Internal Medicine, 2014 - 2017
Weill Cornell Medical College in QatarClass of 2014
Certifications & Licensure
ID State Medical License 2024 - 2026
UT State Medical License 2020 - 2026
OH State Medical License 2017 - 2021
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Faculty Teaching Award University of Utah, 2022
- Harris Foundation Award Case Western Reserve University, 2018
Clinical Trials
- Study to Evaluate Rilzabrutinib in Adults and Adolescents With Persistent or Chronic Immune Thrombocytopenia (ITP) Start of enrollment: 2020 Dec 14
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 3 citationsInherited Disorders of the Fibrinolytic Pathway: Pathogenic Phenotypes and Diagnostic Considerations of Extremely Rare Disorders.Maha Al-Ghafry, Mouhamed Yazan Abou-Ismail, Suchitra S Acharya
Seminars in Thrombosis and Hemostasis. 2025-03-01 - Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis.Amir A Mahmoud, Mariam Mostafa, Ali Abdelhay, Mouhamed Yazan Abou-Ismail, Shruti Chaturvedi
Research and Practice in Thrombosis and Haemostasis. 2025-01-01 - Navigating the inevitable: artificial intelligence and the future of scientific communication.Michael Makris, Mouhamed Yazan Abou-Ismail
Research and Practice in Thrombosis and Haemostasis. 2024-07-01
Abstracts/Posters
- Effect of Obesity on Outcomes after Alternative Donor Allogeneic Hematopoietic Stem Cell Transplant (alloHCT)Mouhamed Yazan Abou-Ismail, MD, University Hospitals Cleveland Medical Center, Cleveland, OH, Leland Metheny III, M.D., Hematology and Oncology, University Hospitals C..., Transplant and Cellular Therapy, 2/2021
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
